Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Carl June
CAR T immunotherapy
Craig Jordan
AML
Michael Savona
MDS and leukemia
Megan McNerney
AML/MDS
Selina Chen-Kiang
Mantle cell lymphoma
Ann-Kathrin Eisfeld
Racial diversity in AML
Katherine Borden
AML
Kasey Leger
pediatric blood cancers
Tak Mak
Immunotherapy
Liran Shlush
pre-leukemia
Cailin Collins
Leukemia and pre-leukemia
Marco Ruella
Immunotherapy for T-cell lymphoma
Daisuke Nakada
preleukemia, leukemia
Coleman Lindsley
AML/MDS
Daniel Thomas
Myelofibrosis
Kimberly Stegmaier
childhood blood cancers
Robert Bradley
MDS
Courtney Jones
AML metabolism
Kirsten Williams
leukemia, immunotherapy
BioInvent International
immunotherapy, indolent NHL, CTCL
Ravindra Majeti
preleukemia, AML
Gaurav Goyal
Erdheim-Chester Disease
Jennifer Trowbridge
aging and leukemia
Julia Maxson
AML
Samuel Taylor
leukemia biology
John Leonard
lymphoma research
Stephen Gottschalk
pediatric leukemia and CAR-T
Piers Patten
COVID-19
Jianhua Yu
myeloma immunotherapy
Bruno Paiva
smoldering myeloma
Sameer Parikh
COVID-19
Markus Muschen
leukemia and lymphoma biology
Takeshi Sugio
T-cell lymphoma
Siegfried Janz
Myeloma immunotherapy
Sigurður Kristinsson
Smoldering myeloma
Jason Butler
aging and leukemia
Aditi Shastri
AML, MDS
Madhav Dhodapkar
multiple myeloma immunotherapy
Nataly Cruz-Rodriguez
T-ALL and metabolism
Adam Olszewski
Follicular and marginal zone lymphoma
Christopher Flowers
clinical trial access
Koichi Takahashi
AML/MDS
Yusuke Isshiki
DLBCL and GCB Lymphomas
Rizwan Romee
Immunotherapy
Faron Pharmaceuticals
immunotherapy, MDS
Thomas Kipps
Hairy Cell Leukemia
Jolanta Grembecka
leukemia therapeutics
Justine Kahn
pediatric leukemia and lymphoma
Robert Orlowski
(Smoldering) Multiple Myeloma
Marc Seifert
Hairy cell leukemia
Ruben Carrasco
Myeloma
Jenny Wang
AML
Christopher Booth
BPDCN
Kerry Rogers
CLL
Michael Rout
follicular lymphoma, CAR T
Keisuke Ito
blood cancer stem cells and MDS metabolism
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Kura Oncology
MLL leukemia, AML
Jennifer Lewis
URM Student
Srividya Swaminathan
pediatric, immunotherapy
Michael Kharas
leukemia
Dimericon Therapeutics
dimericons, blood cancer
Logan Spector
childhood leukemia epidimiology
Hong Wen
AML
Amit Verma
AML/MDS
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Michael Wang
Mantle Cell Lymphoma
Alexey Danilov
lymphoma
Sean Post
diffuse large B-cell lymphoma
Peng Ji
myeloproliferative neoplasms
Nizar Bahlis
Myeloma immunotherapy
Jessica Stewart
Epstein-barr virus and lymphomas
Siddhartha Jaiswal
preleukemia
Omar Abdel-Wahab
Hairy cell leukemia
Liling Wan
AML
Wendy Béguelin
follicular lymphoma
Kevin Shannon
pediatric AML
Jun Qi
Myeloma
Kathleen Sakamoto
pediatric AML
Soheil Meshinchi
pediatric AML
Venkata Lokesh Battula
immunotherapy and AML
Thomas Koehnke
leukemia
Pooja Khandelwal
bone marrow transplantation
Anouchka Laurent
T-cell lymphoma
Robert Kridel
follicular lymphoma
Sheng Li
Aging and AML
Timothy Ley
AML, precision medicine
Yiman Liu
Epigenetics and leukemia
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Michael Keller
COVID-19, immunotherapy
Tomasz Skorski
myeloproliferative neoplasms, AML
Jalpa Doshi
Equity in Access
Ravi Bhatia
transplantation
Christopher Porter
Leukemia, lymphoma
Constellation Pharmaceuticals
myeloproliferative neoplasms
Ryan Wilcox
T-cell lymphoma
Peter Croucher
Multiple Myeloma
Mala Shanmugam
myeloma
Areej El-Jawahri
transplant survivorship
Thorsten Zenz
Hairy cell leukemia
William Matsui
Myeloma
Saar Gill
AML immunotherapy
Steven Treon
Lymphomas and Waldenstrom's
Sisi Chen
leukemia
Michael Green
lymphoma biology
Manyi Wei
acute megakaryoblastic leukemia
Zachary Hunter
Waldenström macroglobulinemia (WM)
Alieen Rowan
Adult T cell leukemia/lymphoma
Affimed
immunotherapy, HL, PTCL
Jonathan Licht
DNA biology, myeloma
Peter Klein
MDS
Jing Yang
Myeloma
F. Lennie Wong
Equity in Access
Paolo Strati
Non-Hodgkin Lymphoma
Mark Hamilton
DLBCL and CAR-T
Nicolas Nassar
pediatric leukemia
Lucy Godley
preleukemia
Pietro Genovese
transplant and AML
Brian Walker
smoldering myeloma, MGUS
Shirong Li
myeloma
Catherine Diefenbach
DLBCL immunology
Catherine Smith
leukemia
Alfred Garfall
myeloma immunotherapy
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Yoke Seng Lee
AML
Dane Vassiliadis
blood cancer biology
Randall Davis
CLL
Helen Parsons
Equity in Access
Nathan Ungerleider
lymphoma biology
Marina Konopleva
MDS/AML metabolism
Eric Pietras
AML
Yibin Yang
Lymphoma
Alex Kentsis
pediatric leukemias
Stephen Nimer
myeloid cancer biology
Jianguo Tao
Mantle Cell Lymphoma
Christian Steidl
B-cell lymphomas
Hao Jiang
leukemia biology
Tycel Phillips
Mantle Cell Lymphoma
Caron Jacobson
lymphoma and immunotherapy
Armin Rashidi
gut bacteria and transplant success
Bailee Kain
AML and African ancestry
Neha Mehta-Shah
T-cell lymphoma
Kirk Schultz
pediatric transplantation
Sarah Tasian
pediatric leukemias
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
John DiPersio
trispecific antibody for AML and MDS
Caner Saygin
T-ALL
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Lawrence Boise
CART and myeloma
Elliot Stieglitz
CMML
Catherine Bollard
pediatric blood cancers and immunotherapy
Amin Sobh
Myeloma biology
Daniel Lucas
bone marrow and leukemia biology
Jonathon Cohen
lymphoma clinical trial access in Georgia
Eric Padron
CMML
Stephen Oh
myeloproliferative neoplasms
Tyler Parsons
MPN and AML
Adam de Smith
pediatric ALL and Down Syndrome
Joachim Yahalom
Lymphoma
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Grzegorz Nowakowski
Clinical trial access
Reina Takeda
AML
George Daley
"off-the-shelf" CAR-T and CAR-NK
Ari Melnick
epigenetics and lymphoma
Lev Kats
myeloma and epigenetics
Enterome
vaccine, FL, MZL
Leandro Cerchietti
DLBCL
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Yubin Zhou
peripheral T cell lymphoma
Oreofe Odejide
Equity in Access
Andrew Lane
BPDCN
Grant Challen
preleukemia, leukemia
Luca Busino
DLBCL
Alec Zhang
myeloma, immunotherapy
Baochun Zhang
immunotherapy
Richard Lock
T-ALL
Tanya Siddiqi
clinical trial access
Stacie Dusetzina
Equity in Access
Ryvu Therapeutics
AML, MDS
Jian Xu
leukemia and MPN biology
Matthew Frank
Lymphoma CART therapy
Mark Dawson
B-ALL and CAR-T resistance
Robert Soiffer
transplantation
Thomas LeBlanc
palliative care
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Roland Walter
Antibody-based AML therapies
Wendy Stock
T-cell ALL
Frederick Locke
lymphoma and immunotherapy
Julia Paczkowska
immunobiology of Hodgkin's disease
Inhye Ahn
CLL
Philippe Armand
follicular lymphoma
Simona Colla
Myeloma biology
Steven Horwitz
T-cell lymphomas
Catriona Jamieson
cancer stem cell biology
Frederike Kramer
MPNs
Suzanne Lentzsch
Myeloma
Sami Malek
blood cancer biology
Lori Muffly
Equity in Access
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Anushree Vichare
Equity in Access
Amer Zeidan
MDS and AML
Sriram Sundaravel
AML stem cells
Matteo Bellone
Smoldering multiple myeloma
Reshmi Parameswaran
immunotherapy for hairy cell leukemia
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Bing Carter
p53 mutant AML
Alison Moskowitz
lymphoma therapeutics
Dan Landau
cancer evolution biology
John Crispino
MPNs, myelofibrosis
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Mendel Goldfinger
MDS/AML trials for the elderly
Bingyi Chen
AML immunotherapy
Jonas Jutzi
myeloproliferative neoplasms
Margaret Shipp
lymphoma biology
Noemí Puig Morón
Myeloma
Lindsey Montefiori
pediatric leukemia
Michaela Reagan
Multiple Myeloma
Jeetayu Biswas
splicing in myeloid diseases
Daniel Starczynowski
MDS and AML
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Juliette Bouyssou
leukemias and gender
Huda Salman
CMML
Qingyu Luo
BPDCN
Adi Nagler
Bronchiolitis obliterans after transplant
Gareth Morgan
smoldering myeloma, MGUS
Eugenio Morelli
Myeloma
Suman Paul
T cell cancers and immunotherapy
Ricky Johnstone
lymphoma and myeloma
Fenghuang Zhan
Myeloma and bone disease
Caroline Arber
myeloma CAR-T
Eirini Papapetrou
blood cancer stem cells
Zhijian Qian
blood cancer stem cells
Martin Dreyling
Mantle Cell Lymphoma
James Rubenstein
Lymphoma of the Central Nervous System
Ana Vujovic
AML
Fahmin Basher
transplant and GvHD
Sahand Hormoz
MPN
Jayna Mistry
aging and leukemias
Sham Mailankody
Myeloma immunotherapy clinical trials
Daniel Pollyea
AML
Maria "Ken" Figueroa
aging and leukemia
Sam Butterworth
CMML
Therese Vu
T-All and MLL
Britta Will
Leukemia and pre-leukemia
Nicoletta Cieri
AML and transplantation
Riccardo Dalla-Favera
lymphoma (DLBCL)
Daniel Herranz
T-ALL
Lakshmi Nayak
brain tumors in lymphoma
Nirav Shah
CAR-T for lymphoma
Alex Herrera
lymphoma and immunotherapy
Anita Kumar
Mantle Cell Lymphoma immunotherapy
George Vassiliou
Leukemia Prevention
Larry Kwak
Mantle cell lymphoma, immunotherapy
Mitchell Geer
leukemia biology
Qing Yi
Novel CAR-T
Gianpietro Dotti
CAR T and AML
Jaehyuk Choi
T-cell lymphoma
Christian Marinaccio
MLL leukemias
Yan Liu
MDS
Jeremy Baeten
AML
Nicola Vannini
Aging and CAR-T success
Brian Dalton
DNA mutations and myeloid cancers
Taishi Yonezawa
AML
Trent Hall
MDS
Jake Shortt
precision therapy for aggressive lymphomas
Rajni Kumari
AML
Timothy Graubert
AML and MDS biology
Arash Alizadeh
blood cancer biology and diagnosis
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Roberta Zappasodi
lymphoma, immunotherapy
Steven Park
follicular lymphoma
Xu Ji
Equity in Access
Ronald Levy
immunotherapies, COVID-19
Mark Murakami
follicular lymphoma
Nitin Jain
CLL
Rong Lu
preleukemia, leukemia
Paul Beavis
immunotherapy in myeloma
G. Greg Wang
DNA biology
Carl Allen
pediatric blood cancers
ImCheck Therapeutics
immunotherapy, AML
Jeffrey Magee
pediatric AML
Enrico Tiacci
Hairy cell leukemia
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Courtney DiNardo
clinical trials, AML
David Fruman
novel combinations
Meng Li
Equity in Access
Sattva Neelapu
DLBCL, CAR T
Maximilian Stahl
AML immunotherapy
Jennifer Woyach
CLL trials
Christine Zhang
AML
Rgenta Therapeutics
RNA-targeting, blood cancer
Abintus Bio
immunotherapy, in vivo CAR
Shannon McKinney-Freeman
transplant biology
Susan Schwab
cancer immunology
Helen Heslop
Immunotherapy
Sergei Doulatov
Leukemias
Christiane Querfeld
T-cell lymphoma
Jaroslaw Maciejewski
bone marrow failure
Shannon Maude
Immunotherapy for ALL